The cognitive consequences of non-central nervous system (non-CNS) cancer and cancer-related treatments did not become the subject of scientific investigation until recently and is still a growing area of research.  Contemporary studies have made it clear that neuropsychology is an integral part of the evaluation and care of individuals with cancer.  Today we talk with Michael Parsons, Ph.D., ABPP-CN, about the evaluation of cognitive change due to cancer and cancer-related treatment, factors that influence cognitive decline in these patients, and how interdisciplinary work can benefit these patients.

Show notes are available at www.NavNeuro.com/50

_________________

If you’d like to support the show, here are a few easy ways:

1) Get APA-approved CE credit for listening to episodes: www.NavNeuro.com/INS 

2) Tell your friends and colleagues about it

3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes

4) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro)

Thanks for listening, and join us next time as we continue to navigate the brain and behavior!

[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]